James Herriott Exact Sciences Corp (EXAS) insider trading activity

James Herriott is SVP, General Counsel & Sec of EXACT SCIENCES CORP. Currently has a direct ownership of 9,866 shares of EXAS, which is worth approximately $581,403. The most recent transaction as insider was on May 01, 2024, when has been sold 30 shares (Common Stock) at a price of $60.15 per share, resulting in proceeds of $1,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.87K

0% 3M change

63.56% 12M change

Total Value Held $581,403

James Herriott Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2024	SELL Open market or private sale	$1,804 $60.15 p/Share	30 Reduced 0.3%	9,866 Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	$11,572 $15.01 p/Share	771 Added 7.23%	9,896 Common Stock
Mar 01 2024	SELL Open market or private sale	$51,133 $59.32 p/Share	862 Reduced 8.63%	9,125 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	1,890 Added 15.91%	9,987 Common Stock
Feb 27 2024	SELL Open market or private sale	$44,601 $56.89 p/Share	784 Reduced 8.83%	8,097 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	1,648 Added 15.65%	8,881 Common Stock
Feb 22 2024	SELL Open market or private sale	$17,395 $59.78 p/Share	291 Reduced 3.87%	7,233 Common Stock
Feb 21 2024	SELL Open market or private sale	$25,522 $61.5 p/Share	415 Reduced 5.64%	6,943 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	581 Added 7.17%	7,524 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	864 Added 10.51%	7,358 Common Stock
Feb 15 2024	SELL Open market or private sale	$25,862 $61.43 p/Share	421 Reduced 6.09%	6,494 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	883 Added 11.32%	6,915 Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	$2,041 $30.02 p/Share	68 Added 1.11%	6,032 Common Stock
Jul 19 2023	SELL Open market or private sale	$130,000 $100.0 p/Share	1,300 Reduced 17.9%	5,964 Common Stock
Jun 08 2023	SELL Open market or private sale	$117,000 $90.0 p/Share	1,300 Reduced 15.18%	7,264 Common Stock
May 10 2023	SELL Open market or private sale	$103,804 $79.85 p/Share	1,300 Reduced 13.18%	8,564 Common Stock
May 01 2023	BUY Grant, award, or other acquisition	$19,212 $30.02 p/Share	640 Added 6.09%	9,864 Common Stock
Feb 28 2023	SELL Open market or private sale	$134,723 $60.55 p/Share	2,225 Reduced 19.43%	9,224 Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	1,887 Added 14.15%	11,449 Common Stock
Feb 22 2023	SELL Open market or private sale	$24,962 $62.72 p/Share	398 Reduced 4.0%	9,562 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	865 Added 7.99%	9,960 Common Stock
Feb 15 2023	SELL Open market or private sale	$26,236 $65.59 p/Share	400 Reduced 4.21%	9,095 Common Stock
Feb 14 2023	BUY Exercise of conversion of derivative security	-	883 Added 8.51%	9,495 Common Stock

James Herriott

SVP, General Counsel & Sec

Madison, WI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Value

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS

Account